The Cooper Companies, Inc.
COO Healthcare Medical Instruments & Supplies
The Cooper Companies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $4.1 billion, up 5.06% from fiscal 2024. In the quarter to July 2026, revenue was flat, EPS grew 357.1%, free cash flow grew 66.0% and total debt rose 2.66%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five; insiders bought in the last twelve months.
Follow COO
The Cooper Companies, Inc. (COO) P/S ratio
As of 16 October 2026, The Cooper Companies, Inc. (COO) trades at a P/S ratio of 2.6×. Over the past ten years it has ranged from 2.4× (September 2026) to 8.2× (April 2021); the current reading is higher than 1% of that period. That is in line with the Medical Instruments & Supplies industry median of 2.5× and below the Healthcare sector median of 3.4×.
P/S ratio, daily
Embed this chart
Annual newest first
| Period | P/S ratio | Change |
|---|---|---|
| FY2025 | 3.4× | (36.37%) |
| FY2024 | 5.3× | 24.52% |
| FY2023 | 4.3× | 5.26% |
| FY2022 | 4.1× | (42.59%) |
| FY2021 | 7.1× | 9.73% |
| FY2020 | 6.5× | 19.50% |
| FY2019 | 5.4× | 8.19% |
| FY2018 | 5.0× | (8.84%) |
| FY2017 | 5.5× | 26.54% |
| FY2016 | 4.3× | 3.93% |
Quarterly newest first
| Period | P/S ratio | Change |
|---|---|---|
| Jul 2026 | 3.3× | 13.64% |
| Apr 2026 | 2.9× | (23.78%) |
| Jan 2026 | 3.8× | 11.83% |
| Oct 2025 | 3.4× | (2.33%) |
| 43 more quarters | Free account |
Against its own ten years
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| BLCO Bausch + Lomb Corporation compare | 1.1× |
| BAX Baxter International Inc. compare | 1.1× |
| AVTR Avantor, Inc. compare | 1.7× |
| SOLV Solventum Corporation compare | 1.8× |
| ATR AptarGroup, Inc. compare | 2.0× |
| TFX Teleflex Incorporated compare | 2.5× |
| ALGN Align Technology, Inc. compare | 2.5× |
| COO The Cooper Companies, Inc. | 2.6× |
| RGEN Repligen Corporation compare | 12.6× |
| Medical Instruments & Supplies industry median | 2.5× |
| Healthcare sector median | 3.4× |
| Market median | 1.9× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on COO
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement